Cargando…

Preclinical Evidence for the Efficacy of CD79b Immunotherapy in B-cell Precursor Acute Lymphoblastic Leukemia

Detalles Bibliográficos
Autores principales:	Lenk, Lennart, Winterberg, Dorothee, Vogiatzi, Fotini, Laqua, Anna, Spory, Lea, Mayar, Ahmad, Dietterle, Anna, Münch, Gina, Vokuhl, Christian, Richter, Julia, Polson, Andrew G., Schüler, Thomas, Kahlert, Ulf D., Peipp, Matthias, Valerius, Thomas, Schrappe, Martin, Cario, Gunnar, Jumaa, Hassan, Hobeika, Elias, Brüggemann, Monika, Alsadeq, Ameera, Schewe, Denis M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2022
Materias:	Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9351922/ https://www.ncbi.nlm.nih.gov/pubmed/35935606 http://dx.doi.org/10.1097/HS9.0000000000000754

Ejemplares similares

CD79a promotes CNS-infiltration and leukemia engraftment in pediatric B-cell precursor acute lymphoblastic leukemia
por: Lenk, Lennart, et al.
Publicado: (2021)

AP-1 Transcription Factor Complex Members FOSB and FOS are Linked With CNS Infiltration and Inferior Prognosis in Childhood T-ALL
por: Spory, Lea, et al.
Publicado: (2023)

Engineering of CD19 Antibodies: A CD19-TRAIL Fusion Construct Specifically Induces Apoptosis in B-Cell Precursor Acute Lymphoblastic Leukemia (BCP-ALL) Cells In Vivo
por: Winterberg, Dorothee, et al.
Publicado: (2021)

Synergism between IL7R and CXCR4 drives BCR-ABL induced transformation in Philadelphia chromosome-positive acute lymphoblastic leukemia
por: Abdelrasoul, Hend, et al.
Publicado: (2020)

Venetoclax enhances the efficacy of therapeutic antibodies in B-cell malignancies by augmenting tumor cell phagocytosis
por: Vogiatzi, Fotini, et al.
Publicado: (2022)

Involvement of the central nervous system in acute lymphoblastic leukemia: opinions on molecular mechanisms and clinical implications based on recent data
por: Lenk, Lennart, et al.
Publicado: (2020)

Perspectives of Fc engineered antibodies in CD19 targeting immunotherapies in pediatric B-cell precursor acute lymphoblastic leukemia
por: Kellner, Christian, et al.
Publicado: (2018)

Myeloid checkpoint blockade improves killing of T-acute lymphoblastic leukemia cells by an IgA2 variant of daratumumab
por: Baumann, Niklas, et al.
Publicado: (2022)

The Small GTPase RHOA Links SLP65 Activation to PTEN Function in Pre B Cells and Is Essential for the Generation and Survival of Normal and Malignant B Cells
por: Vadakumchery, Anila, et al.
Publicado: (2022)

Recurrent DNMT3B rearrangements are associated with unfavorable outcome in dicentric (9;20)-positive pediatric BCP-ALL
por: Antić, Željko, et al.
Publicado: (2023)

Transcriptional and Mutational Profiling of B-Other Acute Lymphoblastic Leukemia for Improved Diagnostics
por: Chouvarine, Philippe, et al.
Publicado: (2021)

Enhancing CDC and ADCC of CD19 Antibodies by Combining Fc Protein-Engineering with Fc Glyco-Engineering
por: Roßkopf, Sophia, et al.
Publicado: (2020)

Enhancement of epidermal growth factor receptor antibody tumor immunotherapy by glutaminyl cyclase inhibition to interfere with CD47/signal regulatory protein alpha interactions
por: Baumann, Niklas, et al.
Publicado: (2021)

PI3K-Mediated Blimp-1 Activation Controls B Cell Selection and Homeostasis
por: Setz, Corinna S., et al.
Publicado: (2018)

Dual Fc optimization to increase the cytotoxic activity of a CD19-targeting antibody
por: Gehlert, Carina Lynn, et al.
Publicado: (2022)

B-cell antigen receptor expression and phosphatidylinositol 3-kinase signaling regulate genesis and maintenance of mouse chronic lymphocytic leukemia
por: Schmid, Vera Kristin, et al.
Publicado: (2022)

Molecular complete remission following combination treatment of daratumumab and venetoclax in an adolescent with relapsed mixed phenotype acute leukemia
por: Stanulla, Martin, et al.
Publicado: (2023)

Anti‐CD22 and anti‐CD79b antibody‐drug conjugates preferentially target proliferating B cells
por: Fuh, Franklin K, et al.
Publicado: (2017)

Tuning B cell responsiveness by antigen receptor isotype
por: Jumaa, Hassan
Publicado: (2015)

Novel NKG2D-directed bispecific antibodies enhance antibody-mediated killing of malignant B cells by NK cells and T cells
por: Lutz, Sebastian, et al.
Publicado: (2023)

Conditional Selection of B Cells in Mice With an Inducible B Cell Development
por: Hobeika, Elias, et al.
Publicado: (2018)

BCR-ABL1-like acute lymphoblastic leukemia in childhood and targeted therapy
por: Cario, Gunnar, et al.
Publicado: (2020)

Malignant transformation in a defined genetic background: proteome changes displayed by 2D-PAGE
por: Pütz, Stephanie M, et al.
Publicado: (2010)

Identification of a Pre-BCR Lacking Surrogate Light Chain
por: Su, Yu-wen, et al.
Publicado: (2003)

Isocitrate dehydrogenase 1 mutation drives leukemogenesis by PDGFRA activation due to insulator disruption in acute myeloid leukemia (AML)
por: Steinhäuser, Sophie, et al.
Publicado: (2022)

PI3K induces B-cell development and regulates B cell identity
por: Abdelrasoul, Hend, et al.
Publicado: (2018)

HER2-specific immunoligands engaging NKp30 or NKp80 trigger NK-cell-mediated lysis of tumor cells and enhance antibody-dependent cell-mediated cytotoxicity
por: Peipp, Matthias, et al.
Publicado: (2015)

Fc-engineering significantly improves the recruitment of immune effector cells by anti-ICAM-1 antibody MSH-TP15 for myeloma therapy
por: Klausz, Katja, et al.
Publicado: (2020)

Death of tonsillar B cells by NETosis
por: Bukhari, Ameera, et al.
Publicado: (2023)

Anti-CD79B Antibody–Drug Conjugate DCDS0780A in Patients with B-Cell Non-Hodgkin Lymphoma: Phase 1 Dose-Escalation Study
por: Herrera, Alex F., et al.
Publicado: (2022)

Design, synthesis and structure-activity relationship study of wollamide B; a new potential anti TB agent
por: Asfaw, Henok, et al.
Publicado: (2017)

Repurposing anthelmintic agents to eradicate resistant leukemia
por: Mezzatesta, Caterina, et al.
Publicado: (2020)

The Gene Expression Classifier ALLCatchR Identifies B-cell Precursor ALL Subtypes and Underlying Developmental Trajectories Across Age
por: Beder, Thomas, et al.
Publicado: (2023)

A novel Fc-engineered human ICAM-1/CD54 antibody with potent anti-myeloma activity developed by cellular panning of phage display libraries
por: Klausz, Katja, et al.
Publicado: (2017)

Specific Targeting of Lymphoma Cells Using Semisynthetic Anti-Idiotype Shark Antibodies
por: Macarrón Palacios, Arturo, et al.
Publicado: (2020)

Identification of ETV6-RUNX1-like and DUX4-rearranged subtypes in paediatric B-cell precursor acute lymphoblastic leukaemia
por: Lilljebjörn, Henrik, et al.
Publicado: (2016)

Oxidation-Specific Epitopes (OSEs) Dominate the B Cell Response in Murine Polymicrobial Sepsis
por: Nicolai, Oliver, et al.
Publicado: (2020)

Event-B-Supported Choreography-Defined Communicating Systems: Correctness and Completeness
por: Benyagoub, Sarah, et al.
Publicado: (2020)

The Determinants of B Cell Receptor Signaling as Prototype Molecular Biomarkers of Leukemia
por: Nicolò, Antonella, et al.
Publicado: (2021)

Molecular requirements of the B‐cell antigen receptor for sensing monovalent antigens
por: Volkmann, Christoph, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_i8j1sqggof7pqskv5g2ahpoltu